| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On October 16, 2007 - Corrected Copy
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1992V-0087
|
| Laser effects for 'Fantasmic' show
|
|
|
|
|
| 1998D-0077
|
| Treatment of osteoarthritis/drugs, devices and biological pt
|
|
|
|
|
| 1998N-0359
|
| Program priorities/Center for Food Safety & Applied Nutrition
|
|
|
|
|
| 2006D-0480
|
| Guidance for Industry on Complementary & Alternative Medicine Products & Their Regulation by the Food D Drug Administration
|
|
|
|
|
| 2006N-0454
|
| Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
|
|
|
|
|
| 2007N-0321
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Evaluation of the Impact of Distraction on Consumer Understanding of Risk and Benefit Information in Direct
|
|
|
|
|
|
|
|
|
| 2007N-0330
|
| Presidential Interagency Working Group on Import Safety; Public Meeting
|
|
|
|
|
| 2007N-0356
|
| BEHIND THE COUNTER AVAILABILITY OF CERTAIN DRUGS; Public Meeting
|
|
|
|
|
| 2007N-0389
|
| Granisetron Hydrochloride Injection and 180-day generic drug exclusivity
|
|
|
|
|
| 2007P-0074
|
| Over-the-Counter (OTC) Cough and Cold Drug Products for Children Under 6 Years of Age
|
|
|
|
|
| 2007P-0235
|
| Change the labeling requirements for eggs sold in the United States
|
|
|
|
|
| 2007P-0398
|
| To permit an New Drug Application ANDA Suitability for Zaleplon Capsules, 7.5 mg
|
|
|
|
|
| 2007V-0397
|
| Laser Light Show
|
|
| |
|
| 1992V-0087
|
| Laser effects for 'Fantasmic' show
|
|
|
|
|
| EXP 2
|
| Disneyland Resort
|
| Vol #:
|
| 1
|
|
|
|
|
| 1998D-0077
|
| Treatment of osteoarthritis/drugs, devices and biological pt
|
|
|
|
|
| C 19
|
| Novartis Pharmaceuticals Corporation
|
| Vol #:
|
| 1
|
|
|
|
|
| 1998N-0359
|
| Program priorities/Center for Food Safety & Applied Nutrition
|
|
|
|
|
| C 131
|
| International Dairy Foods Association
|
| Vol #:
|
| 10
|
|
|
|
|
| 2006D-0480
|
| Guidance for Industry on Complementary & Alternative Medicine Products & Their Regulation by the Food D Drug Administration
|
|
|
|
|
| C 1368
|
| B. Keller
|
| Vol #:
|
| 25
|
|
|
|
|
| 2006N-0454
|
| Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
|
|
|
|
|
| C 4201
|
| R. Vanyo
|
| Vol #:
|
| 35
|
|
|
|
|
| 2007N-0321
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Evaluation of the Impact of Distraction on Consumer Understanding of Risk and Benefit Information in Direct
|
|
|
|
|
|
| |
|
|
|
| C 1
|
| American Medical Association
(AMA)
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0330
|
| Presidential Interagency Working Group on Import Safety; Public Meeting
|
|
|
|
|
| C 25
|
| American Meat Institute (AMI) and The Shelf-Stable Food Processors Association
|
| Vol #:
|
| 1
|
|
|
|
|
| TS 19
|
| The Association of Home Appliance Manufacturers (AHAM)
|
| Vol #:
|
| 2
|
|
|
|
|
| 2007N-0356
|
| Behind The Counter
Availability of Certain Drugs; Public Meeting
|
|
|
|
|
| EAPE 106
|
| Cassagnol, Manouchkathe
|
| Vol #:
|
| 1
|
|
